Harris Williams Advises RQM+ on its Sale to Linden Capital Partners

Rhea-AI Summary

Harris Williams, a global investment bank, has advised RQM+ on its sale to Linden Capital Partners. RQM+ specializes in regulatory and quality consulting for medical devices and diagnostics. The transaction highlights RQM+'s growth potential as outsourcing increases in the medical device sector due to stricter regulatory demands. DFW Capital Partners and Chief Capital, both involved in RQM+'s previous funding, focus on healthcare and lower-middle market investments. Linden, investing exclusively in healthcare, has a substantial track record with over $2.5 billion in investments.

Positive

• RQM+ is well-positioned to benefit from growing outsourcing in the medical device sector.
• The company has an industry-leading platform with strong technical expertise.
• Linden Capital Partners brings significant healthcare investment experience.

Negative

• None.

Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised RQM+, a portfolio company of DFW Capital Partners (DFW) and Chartwell Investments Entrepreneur & Founder Capital (Chief Capital), on its sale to Linden Capital Partners (Linden). RQM+ provides regulatory and quality consulting and engineering for medical devices, in vitro diagnostics and combination products. The transaction was led by Paul Hepper, Nick Owens and Nathan Robertson of the Harris Williams Healthcare & Life Sciences (HCLS) Group.

“We are thrilled to have represented RQM+ and believe that the company is well-positioned to benefit from the growth in outsourcing from medical device OEMs who are faced with increasing regulatory demands amid increasingly complex devices,” said Paul Hepper, a managing director at Harris Williams.

“The management team at RQM+ has built an industry-leading platform known for its technical expertise and strong culture. We look forward to watching the company’s continued growth with its new equity partner,” said Nick Owens, a director at Harris Williams.

RQM+ is a leading medical device and diagnostics focused, regulatory and quality consulting firm. The company delivers transformative solutions by providing an unrivaled collective expertise, fueled by passion for client success. RQM+’s experts are collaborative, laser-focused on client needs and committed to delivering high value solutions that exceed expectations.

DFW is a private equity investment firm focused on lower-middle market companies. The firm concentrates on service companies, with an emphasis on healthcare and outsourced business and industrial support services. DFW is backed by both institutional and high net worth individual investors and has established a more than 20-year track record of success in building leading companies. DFW is headquartered in Teaneck, New Jersey, and maintains an office in Washington, D.C.

Chief Capital is a private investment firm providing flexible private equity for entrepreneurs, family-owned businesses and corporate carve-outs. The firm partners with management owners to help realize their visions and provide long-term capital, resources and expertise to accelerate growth and provide generational liquidity. Chief Capital customizes each investment to meet the objectives of its entrepreneur and family partners. With more than 40 years of experience, Chief Capital focuses on niche lower-middle market companies with emphasis on healthcare services, business services and niche manufacturing segments.

Linden is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: healthcare specialization, integrated private equity and operating experience, and its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005618/en/

FAQ

What company was advised by Harris Williams in its sale to Linden Capital Partners?

Harris Williams advised RQM+ in its sale to Linden Capital Partners.

What is the focus of RQM+?

RQM+ provides regulatory and quality consulting for medical devices and diagnostics.

Who is involved in the investment in RQM+?

DFW Capital Partners and Chief Capital were previously involved in RQM+'s funding before its sale.

What is Linden Capital Partners' investment focus?

Linden Capital Partners focuses exclusively on the healthcare industry.

How much has Linden Capital Partners invested in healthcare companies?

Linden Capital Partners has invested over $2.5 billion in healthcare companies.